Lobbying Spend
—
Filings
21
Firms Hired
1
Active Period
2013–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Drug Quality and Security Act
2013 · fourth_quarter · Firm: CHAMBER HILL STRATEGIES
S.959, the Pharmaceutical Quality, Security and Accountability Act; H.R.3204, the Drug Quality and Security Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.3204
Pharmaceutical Quality, Security, and Accountability Act
2013 · fourth_quarter · Firm: CHAMBER HILL STRATEGIES
S.959, the Pharmaceutical Quality, Security and Accountability Act; H.R.3204, the Drug Quality and Security Act
Client expense: — · Firm income: $60,000
Matched citations: S.959
Drug Quality and Security Act
2013 · fourth_quarter · Firm: CHAMBER HILL STRATEGIES
S.959, the Pharmaceutical Quality, Security and Accountability Act; H.R.3204, the Drug Quality and Security Act
Client expense: — · Firm income: $40,000
Matched citations: H.R.3204
Pharmaceutical Quality, Security, and Accountability Act
2013 · fourth_quarter · Firm: CHAMBER HILL STRATEGIES
S.959, the Pharmaceutical Quality, Security and Accountability Act; H.R.3204, the Drug Quality and Security Act
Client expense: — · Firm income: $40,000
Matched citations: S.959
Drug Quality and Security Act
2013 · third_quarter · Firm: CHAMBER HILL STRATEGIES
S.959, the Pharmaceutical Quality, Security and Accountability Act; H.R.3204, the Drug Quality and Security Act
Client expense: — · Firm income: $40,000
Matched citations: H.R.3204
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: CHAMBER HILL STRATEGIES
S.959, the Pharmaceutical Quality, Security and Accountability Act; H.R.3204, the Drug Quality and Security Act
Client expense: — · Firm income: $40,000
Matched citations: S.959
Safeguarding America's Pharmaceuticals Act of 2013
2013 · third_quarter · Firm: CHAMBER HILL STRATEGIES
S.959, Pharmaceutical Quality, Security, and Accountability Act and H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; FDA issues relative to pharmacy compounding
Client expense: — · Firm income: —
Matched citations: H.R.1919
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: CHAMBER HILL STRATEGIES
S.959, Pharmaceutical Quality, Security, and Accountability Act and H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; FDA issues relative to pharmacy compounding
Client expense: — · Firm income: —
Matched citations: S.959
Source: Senate LDA